Lee's Pharmaceutical Holdings Ltd Reports 32.9% Revenue Growth in 2023
Company

Lee’s Pharmaceutical Holdings Ltd Reports 32.9% Revenue Growth in 2023

RemeGen's 2024 Revenue Soars 58.54% on Strong Product Sales and R&D Growth
Company

RemeGen’s 2024 Revenue Soars 58.54% on Strong Product Sales and R&D Growth

JW Therapeutics Sees 9% Revenue Decline in 2024 Amid Commercial Strategy Shift
Company

JW Therapeutics Sees 9% Revenue Decline in 2024 Amid Commercial Strategy Shift

Ascentage Pharma's Revenue Soars 342% in 2024 on Strong Drug Sales and Partnerships
Company

Ascentage Pharma’s Revenue Soars 342% in 2024 on Strong Drug Sales and Partnerships

Shanghai Pharmaceuticals Reports 5.75% Revenue Growth in 2024 with Innovation Initiatives
Company

Shanghai Pharmaceuticals Reports 5.75% Revenue Growth in 2024 with Innovation Initiatives

YiChang HEC's Yiqibuvir Approved by NMPA for Chronic HCV Infection
CompanyDrug

YiChang HEC’s Yiqibuvir Approved by NMPA for Chronic HCV Infection

Luye Pharma's Shandong Boan Bio Reports 17.5% Revenue Growth in 2024
Company

Luye Pharma’s Shandong Boan Bio Reports 17.5% Revenue Growth in 2024

MicroPort CardioFlow Medtech Reports 7.5% Revenue Growth in 2024 Driven by Global Expansion
Company

MicroPort CardioFlow Medtech Reports 7.5% Revenue Growth in 2024 Driven by Global Expansion

Hengrui Pharmaceuticals Gets NMPA Green Light for HRS-1738 and HRS-5817 Clinical Trials
CompanyDrug

Hengrui Pharmaceuticals Gets NMPA Green Light for HRS-1738 and HRS-5817 Clinical Trials

MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots
Company

MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots

Sanofi's mRNA Chlamydia Vaccine Gains FDA Fast Track Designation
CompanyDrug

Sanofi’s mRNA Chlamydia Vaccine Gains FDA Fast Track Designation

Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions
CompanyDeals

Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions